drugset / Trial / NCT01863849
Tolerability and Immunogenicity Study of Fluval AB Suspension for Injection
Non-randomizedParallel-groupOpen-labelPrevention
Summary
To assess immunogenicity of a single intramuscular injection of Fluval AB suspension for injection (trivalent, seasonal influenza vaccine, active ingredient content: 15 μgHA/0.5mL of seasonal A/H1N1, A/H3N2 and B influenza antigens each), as measured by haemagglutination inhibition (HI) test.
Timeline
- Start
- 2013-08-22
- Primary completion
- 2013-09-17
- Completion
- 2013-09-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluval AB | Vaccine | 0.5 ml | Intramuscular |
Indications
No indication recorded.